Vectra 3d Spot-on Soluzione 3 Pipette 4,7ml 256mg + 22,7mg +1.865mg Cani da 25 A 40 Kg, Tappo Viola

Special warnings for each target species : All dogs in the house should be treated. House cats should only be treated with a veterinary medicine authorized for use in that species. Fleas can infest the dog's basket, kennel and usual resting areas such as rugs and sofas and armchairs. In case of massive flea infestation and initiation of control measures, these areas should be treated with an appropriate insecticide and then vacuumed regularly. Do not use on cats. If this veterinary medicinal product is accidentally ingested it can induce convulsions in cats which can be fatal. In case of accidental exposure, wash the cat with shampoo or soap, and immediately seek advice from a veterinarian. To prevent cats from accidentally coming into contact with this veterinary medicinal product, keep cats away from treated dogs until the application site is dry. It is important to ensure that cats do not rub themselves on the application site of a dog that has been treated with this veterinary medicinal product. In case of such exposure seek immediate advice from a veterinarian.

Special precautions for use in animals : For external use only. The safety of this veterinary medicinal product has not been proven in dogs less than 7 weeks of age or weighing less than 1.5 kg.
Care should be taken to avoid contact between this veterinary medicinal product and the dog's eyes. Attack of a single tick after treatment cannot be ruled out. For this reason, the transmission of infectious diseases cannot be completely excluded if conditions are favorable. The veterinary medicinal product remains effective when treated animals are immersed in water (e.g. when swimming, bathing). Repeated immersion in water weekly for one month and starting 48 hours after treatment, as well as shampooing 2 weeks after treatment, has no effect on the efficacy of this veterinary medicinal product. However, the duration of effectiveness can be reduced with frequent shampooing, or bathing within 48 hours after treatment. Treated dogs should not be allowed to enter waterways for 48 hours after treatment to avoid adverse reactions to aquatic organisms.

Special precautions to be taken by the person administering the product : Do not eat, drink or smoke when handling the veterinary medicinal product. Wash hands thoroughly and immediately after use. This veterinary medicinal product causes eye and skin irritation. Avoid contact with the skin. In case of accidental spillage on the skin, wash immediately with soap and water. If the veterinary medicinal product accidentally comes into contact with the eyes, the eyes should be rinsed thoroughly with water. If eye or skin irritation persists, or if the veterinary medicinal product is accidentally ingested, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to any of the components should avoid contact with the veterinary medicinal product. Children should not touch treated dogs for at least four hours after administration of the veterinary medicinal product. It is therefore advisable to treat dogs in the evening, or before taking them for a walk. On the day of treatment, treated dogs should not be allowed to sleep with their owners, especially children. Used applicators must be disposed of immediately and not left in the sight and reach of children. Wait for the application site to dry before allowing treated dogs to come into contact with fabrics or objects.

Overdose: Except for local redness of the skin and changes in the appearance of the coat where the medicinal product was applied, no adverse reactions were observed in healthy puppies aged 7 weeks, treated topically 7 times at 2 week intervals. and up to 5 times the maximum recommended dosage. In case of accidental ingestion at the maximum recommended dosage, vomiting, salivation and diarrhea may appear but should disappear without treatment.

PHARMACOTHERAPEUTIC CATEGORY

Veterinary medicine.                                                                                    

STORAGE

Keep out of the sight and reach of children. This veterinary medicinal product does not require any special storage conditions. Do not use this veterinary medicinal product after the expiry date which is stated on the carton and spot-on applicator (after “EXP / EXP”).

CONTRAINDICATIONS / EFF. SECONDAR.

Do not use on cats (see “Special warnings”). Due to their particular physiology and inability to metabolise permethrin (one of the active ingredients in this product), this veterinary medicinal product should not be used on cats. When applied to a cat, or ingested by a cat who has actively rubbed itself on a recently treated dog, this veterinary medicinal product can cause severe harmful reactions. Do not use in case of hypersensitivity to the active substances or to any of the excipients.

NAME

Vectra® 3D spot-on solution for dogs weighing 1.5-4 kg
Vectra® 3D spot-on solution for dogs weighing 4-10 kg
Vectra® 3D spot-on solution for dogs weighing 10-25 kg
Vectra® 3D spot-on solution for dogs weighing 25-40 kg
Vectra® 3D spot-on solution for dogs> 40 kg
Dinotefuran / pyriproxyphene / permethrin

SIDE EFFECTS

Transient erythema, pruritus or other signs of discomfort at the application site have been reported very rarely and usually disappear without treatment and within 24 hours after administration of the medicinal product. Gastrointestinal symptoms (stomach or intestines) such as vomiting or diarrhea have also been reported very rarely. Transient aesthetic effects (greasy, matted appearance of the coat and accumulations) have been reported very rarely at the application site, however these effects are usually no longer visible after 48 hours.

The frequency of adverse reactions is defined using the following conventions:
- very common (more than 1 in 10 animals show adverse reactions during one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports)

If serious adverse reactions or other reactions not mentioned in this leaflet occur, please inform your veterinarian.

PREGNANCY AND BREASTFEEDING

The safety of the veterinary medicinal product in bitches has not been established during pregnancy and lactation. The use of the veterinary medicinal product in pregnant and lactating bitches or in dogs intended for breeding should be based on the benefit-risk assessment by the responsible veterinarian. Laboratory studies with each of the components (dinotefuran, pyriproxyphene and permethrin) in rats and rabbits did not provide any evidence of toxic effects on the pregnant or lactating animal, or toxic effects on the embryo or fetus. Dinotefuran has been proven to cross the blood-mammary barrier of lactating animals. N-methylpyrrolidone, an excipient of the veterinary medicinal product, has been shown to cause fetal malformations leading to birth defects in laboratory animals.

INDICATIONS

Fleas: This veterinary medicine kills fleas in infested animals and prevents further infestations for one month. It is effective against the following dog fleas (Ctenocephalides canis and Ctenocephalides felis). This veterinary medicinal product also prevents the multiplication of fleas for two months after application by inhibiting the opening of the eggs (oocidal activity) and by inhibiting the transformation of immature fleas into adult fleas. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD), an inflammation of the skin.

Ticks: This veterinary medicinal product kills and repels ticks (Rhipicephalus sanguineus and Ixodes ricinus are monitored for one month; Dermacentor reticulatus for up to three weeks). If ticks are present when the veterinary medicinal product is applied, they may not all be killed within the first 48 hours but may die within a week. To remove ticks, the use of a special device for removing ticks is recommended.

Sand flies, mosquitoes and flies: this veterinary medicinal product repels (prevents bites) of flying insects such as sand flies (Phlebotomus perniciosus), mosquitoes (Culex pipiens, Eades aegypti) and flies (Stomoxys calcitrans) for one month after application. It also kills mosquitoes (Aedes aegypti) and flies for one month after application.

DOSAGE

Dog weight (kg)

Applicator cap color

Volume (ml)

Applicator to use

For dogs from 1.5-4 kg

Yellow

0.8

1 applicator from Vectra® 3D for dogs from 1.5 - 4 kg

For dogs from 4-10 kg

Green

1.6

1 applicator from Vectra® 3D for dogs from 4 - 10 kg

For dogs from 10-25 kg

Blue

3.6

1 applicator from Vectra® 3D for dogs from 10 - 25 kg

For dogs from 25-40 kg

Violet

4.7

1 applicator from Vectra® 3D for dogs from 25 - 40 kg

For dogs> 40 kg

Red

8.0

1 applicator from Vectra® 3D for dogs> 40 kg

ACTIVE PRINCIPLES

Dog weight (kg)

Applicator cap color

Volume (ml)

Dinotefuran (mg)

Pyriproxyphene (mg)

Permethrin (mg)

For dogs from 1.5-4 kg

Yellow

0.8

44

3.9

317

For dogs from 4-10 kg

Green

1.6

87

7.7

635

For dogs from 10-25 kg

Blue

3.6

196

17.4

1429

For dogs from 25-40 kg

Violet

4.7

256

22.7

1865

For dogs> 40 kg

Red

8.0

436

38.7

3175

TARGET SPECIES

Dogs.

WAITING TIME

Not relevant.

METHOD OF DISPENSATION

Non-repeatable recipe.

USE / ROUTE OF ADMINISTRATION

Topical.